Real‐World Evidence in EU Medicines Regulation: Enabling Use and Establishing Value-Reference-Cited by-同舟云学术

Real‐World Evidence in EU Medicines Regulation: Enabling Use and Establishing Value

Published:2021-11-19 Issue:1 Volume:111 Page:21-23
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Arlett Peter¹,Kjær Jesper²,Broich Karl³,Cooke Emer¹

Affiliation:

1. European Medicines Agency Amsterdam Netherlands

2. Danish Medicines Agency Copenhagen Denmark

3. BfArM Bonn Germany

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2479

Reference14 articles.

1. Marketing Authorization Applications Made to the European Medicines Agency in 2018–2019: What was the Contribution of Real‐World Evidence?;Flynn R.;Clin. Pharmacol. Ther.,2022

2. Considerations for pharmacoepidemiological analyses in the SARS‐CoV ‐2 pandemic

3. European medicines agencies network strategy to 2025.

4. .

5. Real‐World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: A nationwide retrospective cohort study with a non-inferiority primary objective;Lung Cancer;2024-10

2. How Real-World Data Can Facilitate the Development of Precision Medicine Treatment in Psychiatry;Biological Psychiatry;2024-10

3. SATURN: assessing the feasibility of utilising existing registries for real-world evidence data collection to meet patients, regulatory, health technology assessment and payer requirements;Orphanet Journal of Rare Diseases;2024-09-12

4. Generating real‐world evidence on diabetes technology using the CareLink Personal data management system;Diabetes, Obesity and Metabolism;2024-09-04

5. Real‐World Evidence Application in Translational Medicine: Making Use of Prescription Claims to Inform Drug–Drug Interactions of a New Psoriasis Treatment;The Journal of Clinical Pharmacology;2024-08-28